Approach: Targeting the patient, not the pathogen.
Through this approach, our aim is to:
- Develop a new class of drug that blocks a virus or a
bacterium through a common mechanism - Treat a current infection and teach your immune system
to prevent reoccurrence - Resist development of drug resistance
- Fight diseases in the lungs, kidneys, bones and brain
- Create permanent solutions to common ailments
Welcome to Inhibikase Therapeutics where we focus on innovation. We are developing preventative and curative treatments for infectious diseases that affect more than 100 million patients worldwide. Products under development include treatments for:
- Our Blog
- Contribute
- Investors